Health Care

Commentary

Dems’ Reconciliation Bill Would Push US Economy Over Cliff

Inflation is at its highest level in four decades, according to federal data out last week. Senate Democrats say they have a solution — their newly revamped budget reconciliation bill, which would levy price controls on prescription drugs and provide billions in subsidies for health insurance sold through Obamacare’s exchanges. How this proposal ...
Commentary

Stop funneling more money toward failing Affordable Care Act

Democrats in Congress are scrambling to extend the enhanced Obamacare subsidies signed into law by President Biden last year as part of the American Rescue Plan Act. It’s no mystery why. If lawmakers allow these premium tax credits to expire — as they’re set to at the end of this year — ...
Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
Commentary

It’s Time To Cure The FDA’s Regulatory Sclerosis

Late last month, the Food and Drug Administration advised COVID-19 vaccine manufacturers to develop booster shots aimed at the omicron variant of the virus. Regulators hope the shots will be ready by the fall. That will probably be too late to stop BA.5, the highly transmissible subvariant that has quickly become the dominant strain in ...
Commentary

Congress: To prevent addiction, empower physicians and patients to choose non-opioids

Every month, it seems, the United States smashes another unenviable record when it comes to drug addiction and overdose statistics. According to the Centers for Disease Control and Prevention (CDC), the latest data show a jaw-dropping 108,000 overdose deaths in 2021. America’s families and communities are reeling — and the federal government ...
Commentary

Improving Access to Paxlovid Long Overdue

The following op-ed has been authored by a non-clinician, it does not constitute medical advice. In an effort to boost access to the antiviral Paxlovid, the Food and Drug Administration (FDA) will now allow pharmacists to prescribe the medicine; the agency announced this last week, on July 6. Previously, patients seeking the ...
Commentary

‘Build Back Better’ would tear down patients’ hope for better medicines

Congressional Democrats are working to revive the multi-trillion-dollar spending package once dubbed “Build Back Better.” They intend to finance this wave of spending in part by siphoning money away from life-saving research on diseases like cancer, heart disease, and Alzheimer’s. That would be the chief consequence of a widely-discussed provision ...
Commentary

New price transparency rule will help patients

This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Commentary

New price transparency rule will help patients

This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Blog

An Answer to Our Broken Health Insurance

Even though an increasing share of Americans have health insurance, positive health outcomes and access to health services are actually decreasing, as found in a 2021 study by PRI senior fellow Wayne Winegarden. Why? The insurance model in the United States is deeply broken for many reasons. But it is ...
Commentary

Dems’ Reconciliation Bill Would Push US Economy Over Cliff

Inflation is at its highest level in four decades, according to federal data out last week. Senate Democrats say they have a solution — their newly revamped budget reconciliation bill, which would levy price controls on prescription drugs and provide billions in subsidies for health insurance sold through Obamacare’s exchanges. How this proposal ...
Commentary

Stop funneling more money toward failing Affordable Care Act

Democrats in Congress are scrambling to extend the enhanced Obamacare subsidies signed into law by President Biden last year as part of the American Rescue Plan Act. It’s no mystery why. If lawmakers allow these premium tax credits to expire — as they’re set to at the end of this year — ...
Blog

Drug Price Controls Are Not the Solution to Another Bad Inflation Report

The July 13th report on consumer price inflation (CPI-U) confirmed what we all already knew – prices have become unaffordable. Consumer price inflation rose 9.1 percent over the last year, which is the fastest inflation rate in 40+ years. The impetus for this current bout of inflation is not mysterious. ...
Commentary

It’s Time To Cure The FDA’s Regulatory Sclerosis

Late last month, the Food and Drug Administration advised COVID-19 vaccine manufacturers to develop booster shots aimed at the omicron variant of the virus. Regulators hope the shots will be ready by the fall. That will probably be too late to stop BA.5, the highly transmissible subvariant that has quickly become the dominant strain in ...
Commentary

Congress: To prevent addiction, empower physicians and patients to choose non-opioids

Every month, it seems, the United States smashes another unenviable record when it comes to drug addiction and overdose statistics. According to the Centers for Disease Control and Prevention (CDC), the latest data show a jaw-dropping 108,000 overdose deaths in 2021. America’s families and communities are reeling — and the federal government ...
Commentary

Improving Access to Paxlovid Long Overdue

The following op-ed has been authored by a non-clinician, it does not constitute medical advice. In an effort to boost access to the antiviral Paxlovid, the Food and Drug Administration (FDA) will now allow pharmacists to prescribe the medicine; the agency announced this last week, on July 6. Previously, patients seeking the ...
Commentary

‘Build Back Better’ would tear down patients’ hope for better medicines

Congressional Democrats are working to revive the multi-trillion-dollar spending package once dubbed “Build Back Better.” They intend to finance this wave of spending in part by siphoning money away from life-saving research on diseases like cancer, heart disease, and Alzheimer’s. That would be the chief consequence of a widely-discussed provision ...
Commentary

New price transparency rule will help patients

This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Commentary

New price transparency rule will help patients

This month, a federal rule requiring certain private health plans to disclose the rates they pay providers for covered healthcare services takes effect. The Trump-era regulation, along with a similar rule requiring hospitals to publish their prices, is an example of the previous administration’s drive to make the healthcare system more transparent. Such transparency ...
Blog

An Answer to Our Broken Health Insurance

Even though an increasing share of Americans have health insurance, positive health outcomes and access to health services are actually decreasing, as found in a 2021 study by PRI senior fellow Wayne Winegarden. Why? The insurance model in the United States is deeply broken for many reasons. But it is ...
Scroll to Top